All In Biotech

Free tool

FAERS Monitor: Daraprim

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 008578 or its brand name (Daraprim, Pyrimethamine). Reports on generic versions are filed under their own applications.

Reports

1,270

Serious

980

77% of reports

Hospitalization

540

Death reported

221

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use164
  • nausea134
  • vomiting101
  • pancytopenia91
  • drug ineffective73
  • neutropenia72
  • pyrexia64
  • headache63
  • death50
  • dizziness50
  • acute kidney injury49
  • rash49
  • cerebral toxoplasmosis47
  • diarrhoea47
  • thrombocytopenia43

Reports by year received

View as table
YearReports
200422
200516
200613
200716
200823
200927
201024
201119
201218
201321
201429
201526
201677
201785
2018128
2019103
2020136
2021107
2022125
202379
202472
202557
202647

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,889 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
cerebral toxoplasmosisSignal47878.4658.538,290
pancytopeniaSignal9127.022.22,256
neutropeniaSignal728.87.0491
thrombocytopeniaSignal436.44.7190
acute kidney injurySignal495.34.0168
vomitingSignal1013.63.0187
off label useSignal1643.12.7242
pyrexiaSignal643.12.488
nauseaSignal1342.82.4160
rash491.91.419
headache631.71.317
dizziness501.71.313
diarrhoea471.20.91
death501.00.70
drug ineffective730.90.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.